Orchestra BioMed Holdings Balance Sheet Health
Financial Health criteria checks 6/6
Orchestra BioMed Holdings has a total shareholder equity of $46.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $75.3M and $29.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$66.93m |
| Equity | US$46.22m |
| Total liabilities | US$29.10m |
| Total assets | US$75.32m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: OBIO's short term assets ($68.6M) exceed its short term liabilities ($16.2M).
Long Term Liabilities: OBIO's short term assets ($68.6M) exceed its long term liabilities ($12.9M).
Debt to Equity History and Analysis
Debt Level: OBIO is debt free.
Reducing Debt: OBIO had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: OBIO has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: OBIO has sufficient cash runway for 1.3 years if free cash flow continues to reduce at historical rates of 25.2% each year.